ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Nurexone Biologic Inc

Nurexone Biologic Inc (NRX)

0.59
-0.01
(-1.67%)
Closed May 04 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.59
Bid
0.58
Ask
0.61
Volume
11,000
0.58 Day's Range 0.61
0.185 52 Week Range 1.19
Market Cap
Previous Close
0.60
Open
0.60
Last Trade
1000
@
0.59
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
168,997
Shares Outstanding
48,249,000
Dividend Yield
-
PE Ratio
-7.82
Earnings Per Share (EPS)
-0.08
Revenue
-
Net Profit
-3.64M

About Nurexone Biologic Inc

Sector
Miscellaneous Metal Ores,nec
Industry
Pharmaceutical Preparations
Headquarters
Toronto, Ontario, Can
Founded
2011
Nurexone Biologic Inc is listed in the Miscellaneous Metal Ores sector of the TSX Venture Exchange with ticker NRX. The last closing price for Nurexone Biologic was $0.60. Over the last year, Nurexone Biologic shares have traded in a share price range of $ 0.185 to $ 1.19.

Nurexone Biologic currently has 48,249,000 shares outstanding. The market capitalization of Nurexone Biologic is $28.47 million. Nurexone Biologic has a price to earnings ratio (PE ratio) of -7.82.

NRX Latest News

Shares of Biopharma Up After News of Uplisting

When firms uplist to a higher exchange, they gain visibility and greater access to investors. And today, news of a strategic expansion in the United States is sending shares of this biopharma To...

NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility

TORONTO and HAIFA, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company is pleased...

NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine

TORONTO and HAIFA, Israel, April 19, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased...

NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update

TORONTO and HAIFA, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, developing...

Gross Proceeds Close of $4M CAD Generated for NurExone From Warrants Exercise

TORONTO and HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), is pleased to announce that, the Company completed...

In Preparation for Expected Human Clinical Trials, NurExone Signs Agreement for Large Scale Preclinical Testing for Its Spinal Cord Injury Therapy, ExoPTEN

TORONTO and HAIFA, Israel, March 22, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, developing...

NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, developing...

NurExone establishing State-of-the-Art Research and Development Facility in Haifa, Israel

TORONTO and HAIFA, Israel, March 08, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, finalized...

NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit

TORONTO and HAIFA, Israel, March 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased...

Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies

For anyone with a spinal cord injury (SCI), time is of the essence. The typical treatment scenario involves immobilization and surgery as quickly as possible. After that, managing To read the full...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-9.230769230770.650.650.58370660.6136747CS
4-0.15-20.27027027030.740.750.57354500.64689012CS
12-0.17-22.36842105260.761.190.4451689970.8258639CS
260.2996.66666666670.31.190.261155580.76689283CS
520.2996.66666666670.31.190.185753060.74381092CS
156-0.21-26.250.81.190.1515970.71255384CS
260-0.21-26.250.81.190.1515970.71255384CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
janice shell janice shell 2 minutes ago
Corn is cheap and abundant during the summer, and for the rest of the year, we have frozen. Corn pancakes--or fritters--were popular when I was a kid, too. And probably we should all make 'em once in a while.

The difference--to the extent that there is one--seems to be that the fritte
Monksdream Monksdream 3 minutes ago
LTRN under $10
https://investorshub.advfn.com/uimage/uploads/2024/5/4/zrchxIMG_8011.gif
LTRN
Chartmaster Chartmaster 5 minutes ago
Yeah, you se those idiots on the weekends, that's why I like to go Thursdays, have not gone in a while as OTC satisfies my gambling addiction.
GEMZ needs to close 9's or better to see it gain wings!
GEMZ
Huggy Bear Huggy Bear 6 minutes ago
Right here.

If you're going to gamble, you better be able to read the room.
RWGI
Monksdream Monksdream 6 minutes ago
IGMS under $10
https://investorshub.advfn.com/uimage/uploads/2024/5/4/bcoedIMG_8010.gif
IGMS
lucky, mydog lucky, mydog 7 minutes ago
SLAPP stands for Strategic Lawsuit Against Public Participation. SLAPP suits are lawsuits that are intended to silence critics by making them pay for a legal defense until they stop their criticism. SLAPP suits are also known as intimidation lawsuits.
SONG
Seminole Red Seminole Red 8 minutes ago
did you have Kang in your bets....he did good today
Monksdream Monksdream 8 minutes ago
WVE under $10
https://investorshub.advfn.com/uimage/uploads/2024/5/4/eyohhIMG_8009.gif
WVE
4retire 4retire 8 minutes ago
They issued 40 million to pay off debt in February. Read the 10k last night from KULR website
KULR
mzasif mzasif 9 minutes ago
Inspection approval by monday...huge!
BLEG
MightyX MightyX 9 minutes ago
You eat your donut verbiage..lotta holes in sentences..Lmao
TPTW
nowwhat2 nowwhat2 10 minutes ago
Glory, Glory, hallelujah!
Glory, glory, hallelujah!
Glory, glory, hallelujah!
His truth is marching on.......


https://investorshub.advfn.com/uimage/uploads/2024/5/4/vkcrhbtc_555_4_30d_1pm_snip.jpg



https://investorshub.advfn.c
BTCUSD
irishintelligence irishintelligence 10 minutes ago
Total number of shares is 5,800,000,000. At $2.00 per share the market cap would be $11.6 billion.

At a price-to-earnings ratio of 15, the company would need to have earnings of $774 million to reach a share price of $2.00. This is highly unlikely in year 1.

However,
SPZI
Maria56 Maria56 10 minutes ago
You can ask DB for the link since he is the host.
Oh? Did I miss when Moon Equity Holdings announced that DB was its official spokesperson? Or that DB would be having a conversation with the "ENTIRE new management team?" Or that anyone needed to ask DB for the link?
https://investorshu
MONI
wadegarret wadegarret 10 minutes ago
Value- SMCI

This article says they didn't meet revenue estimates...

https://finance.yahoo.com/news/super-micro-forecasts-quarterly-revenue-200957932.html
SMCI
Monksdream Monksdream 10 minutes ago
RAPT under $10
https://investorshub.advfn.com/uimage/uploads/2024/5/4/i[pakIMG_8008.gif
RAPT
JohnnyBlaze JohnnyBlaze 12 minutes ago
Thoughts on targets with NHYF
NHYF
Monksdream Monksdream 12 minutes ago
ZYME under $10
https://investorshub.advfn.com/uimage/uploads/2024/5/4/bokctIMG_8007.gif
ZYME
GStockz GStockz 13 minutes ago
Turned out to be a piece of junk.
CRGEQ
want more want more 13 minutes ago
TMaga. You show proof of what is going on. Get ready for 20 copy and paste fo 2 and 3 year old news.
HCMC
JohnnyBlaze JohnnyBlaze 13 minutes ago
I like the way it’s held this level, shows strength and interest
NHYF
timberwolf7 timberwolf7 14 minutes ago
Which one said there is NO EVIDENCE of issues related to the poison jabs??
And yes, they are afraid to say it outloud because if they do, the COMMIE PARTY goes after them for daring to say it outloud.
Yep, the same COMMIE PARTY that FORCED these jabs onto people, wrecked their lives,
DJT
steez steez 14 minutes ago
Bull run on the way next week imo loading more shib pepe go all the chart looking good ..........
SHIBUSD

Your Recent History

Delayed Upgrade Clock